Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
BJU International|September 3, 2011
Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional studyAlessandro Antonelli, Vincenzo Ficarra, Roberto Bertini, et al.
European Urology|February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell CarcinomaJens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology|December 13, 2022
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology|October 17, 2022
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines PanelUmberto Capitanio, Jens Bedke, Laurence Albiges, et al.
European Urology|December 11, 2017
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal CancerThomas Powles, Laurence Albiges, Michael Staehler, et al.
Journal of Clinical Medicine|March 28, 2026
Cancer-Specific Mortality in Sarcomatoid Renal Cell Carcinoma: A Histological Subtype-Controlled AnalysisMichele Nicolazzini, Calogero Catanzaro, Federico Polverino, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 UpdateAxel Bex, Yasmin Abu Ghanem, Laurence Albiges, et al.
The Journal of Urology|May 29, 2016
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell CarcinomaAlessandro Larcher, Umberto Capitanio, Carlo Terrone, et al.
European Urology|June 2, 2021
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of CareJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology|September 20, 2020
Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter CollaborationEduard Roussel, Giovanni Tasso, Riccardo Campi, et al.
Pageof 23